246 related articles for article (PubMed ID: 31492108)
1. Point-of-care measurement of activated clotting time for cardiac surgery as measured by the Hemochron signature elite and the Abbott i-STAT: agreement, concordance, and clinical reliability.
Dirkmann D; Nagy E; Britten MW; Peters J
BMC Anesthesiol; 2019 Sep; 19(1):174. PubMed ID: 31492108
[TBL] [Abstract][Full Text] [Related]
2. Point-of-Care Measurement of Kaolin Activated Clotting Time during Cardiopulmonary Bypass: A Single Sample Comparison between ACT Plus and i-STAT.
Vranken NPA; Theelen AJAJ; Orbons T; Barenbrug PJC; Weerwind PW
J Extra Corpor Technol; 2021 Mar; 53(1):57-61. PubMed ID: 33814607
[TBL] [Abstract][Full Text] [Related]
3. Transition from Hemochron Response to Hemochron Signature Elite Activated Clotting Time Devices in a Congenital Cardiac Surgery Practice.
Matte GS; Howe RJ; Ibla J; Emani S; Emani SM
J Extra Corpor Technol; 2019 Dec; 51(4):221-226. PubMed ID: 31915405
[TBL] [Abstract][Full Text] [Related]
4. A comparative analysis of four activated clotting time measurement devices in cardiac surgery with cardiopulmonary bypass.
Li H; Serrick C; Rao V; Yip PM
Perfusion; 2021 Sep; 36(6):610-619. PubMed ID: 32885714
[TBL] [Abstract][Full Text] [Related]
5. Correlations between activated clotting time values and heparin concentration measurements in young infants undergoing cardiopulmonary bypass.
Guzzetta NA; Monitz HG; Fernandez JD; Fazlollah TM; Knezevic A; Miller BE
Anesth Analg; 2010 Jul; 111(1):173-9. PubMed ID: 20519414
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a new point-of-care celite-activated clotting time analyzer in different clinical settings. The i-STAT celite-activated clotting time test.
Paniccia R; Fedi S; Carbonetto F; Noferi D; Conti P; Bandinelli B; Giusti B; Evangelisti L; Pretelli P; Palmarini MF; Abbate R; Prisco D
Anesthesiology; 2003 Jul; 99(1):54-9. PubMed ID: 12826842
[TBL] [Abstract][Full Text] [Related]
7. Intraoperative Monitoring of Heparin: Comparison of Activated Coagulation Time and Whole Blood Heparin Measurements by Different Point-of-Care Devices with Heparin Concentration by Laboratory-Performed Plasma Anti-Xa Assay.
Thompson TZ; Kunak RL; Savage NM; Agarwal S; Chazelle J; Singh G
Lab Med; 2019 Oct; 50(4):348-356. PubMed ID: 31053856
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Point-of-Care ACT Coagulometers and Anti-Xa Activity During Cardiopulmonary Bypass.
Falter F; MacDonald S; Matthews C; Kemna E; Cañameres J; Besser M
J Cardiothorac Vasc Anesth; 2020 Nov; 34(11):2921-2927. PubMed ID: 32620484
[TBL] [Abstract][Full Text] [Related]
9. Activated clotting time systems vary in precision and bias and are not interchangeable when following heparin management protocols during cardiopulmonary bypass.
Welsby IJ; McDonnell E; El-Moalem H; Stafford-Smith M; Toffaletti JG
J Clin Monit Comput; 2002 Jul; 17(5):287-92. PubMed ID: 12546261
[TBL] [Abstract][Full Text] [Related]
10. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
Ganter MT; Monn A; Tavakoli R; Genoni M; Klaghofer R; Furrer L; Honegger H; Hofer CK
Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
[TBL] [Abstract][Full Text] [Related]
11. Clinical monitoring of activated clotting time during cardiothoracic surgery: comparing the Hemochron
Hoffmann RF; Horsten S; Mariani MA; de Vries AJ
Perfusion; 2023 Mar; 38(2):285-291. PubMed ID: 34596463
[TBL] [Abstract][Full Text] [Related]
12. Comparison of ACT point-of-care measurements: repeatability and agreement.
Bosch YP; Ganushchak YM; de Jong DS
Perfusion; 2006 Jan; 21(1):27-31. PubMed ID: 16485696
[TBL] [Abstract][Full Text] [Related]
13. Comparison of activated clotting times obtained using Hemochron and Medtronic analysers in patients receiving anti-thrombin therapy during cardiac catheterisation.
Chia S; Van Cott EM; Raffel OC; Jang IK
Thromb Haemost; 2009 Mar; 101(3):535-40. PubMed ID: 19277416
[TBL] [Abstract][Full Text] [Related]
14. Comparison of activated clotting times measured using the Hemochron Jr. Signature and Medtronic ACT Plus during cardiopulmonary bypass with acute normovolemic haemodilution.
Lee JM; Park EY; Kim KM; Won JC; Jung TK; Lee SK
J Int Med Res; 2018 Feb; 46(2):873-882. PubMed ID: 28974132
[TBL] [Abstract][Full Text] [Related]
15. Interchangeability of activated clotting time values across different point-of-care systems.
Thenappan T; Swamy R; Shah A; Nathan S; Nichols J; Bond L; Jolly N
Am J Cardiol; 2012 May; 109(9):1379-82. PubMed ID: 22341924
[TBL] [Abstract][Full Text] [Related]
16. The Hemochron Response RxDx heparin and protamine dosing system.
Jaryno SA; Zucker ML; LaDuca FM
J Extra Corpor Technol; 2004 Sep; 36(3):258-62. PubMed ID: 15559745
[TBL] [Abstract][Full Text] [Related]
17. Clinical Evaluation of Measuring the ACT during Elective Cardiac Surgery with Two Different Devices.
Falter F; Razzaq N; John M; Fassl J; Maurer M; Ewing S; Hofmeyr R
J Extra Corpor Technol; 2018 Mar; 50(1):38-43. PubMed ID: 29559753
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulation monitoring during vascular surgery: accuracy of the Hemochron low range activated clotting time (ACT-LR).
Tremey B; Szekely B; Schlumberger S; François D; Liu N; Sievert K; Fischler M
Br J Anaesth; 2006 Oct; 97(4):453-9. PubMed ID: 16873382
[TBL] [Abstract][Full Text] [Related]
19. Hand-held personal digital assistant program for the HEMOCHRON RxDx heparin and protamine dosing system.
El Rouby S; Rinehart K; Zucker ML; LaDuca FM
J Extra Corpor Technol; 2003 Sep; 35(3):212-7. PubMed ID: 14653423
[TBL] [Abstract][Full Text] [Related]
20. Assessment of Heparin Anticoagulation Measured Using i-STAT and Hemochron Activated Clotting Time.
Maslow A; Chambers A; Cheves T; Sweeney J
J Cardiothorac Vasc Anesth; 2018 Aug; 32(4):1603-1608. PubMed ID: 29503117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
